Overview:
As medicine shortages remain a key focus for healthcare providers, regulators and industry alike, understanding the latest developments has never been more important. At this Stakeholder Breakfast, Ellen McGrath, Medicines Shortages and Borderline Classification Manager at the HPRA, will share valuable insights into the current landscape, regulatory priorities, and the collaborative approaches helping to strengthen medicine supply in Ireland.
—–
Meet the speaker:
Ellen McGrath, Medicine Shortages and Borderline Classification (MSBC) Manager – Health Products Regulatory Authority (HPRA)
Ellen is a graduate of the University of East Anglia School of Pharmacy UK. Ellen completed her pharmacy training and worked as a resident pharmacist in Leeds Teaching Hospitals (LTH) and during this time also completed a Diploma in Clinical Pharmacy with the University of Leeds. Ellen has amassed 15 years’ experience both in clinical and corporate roles. Prior to commencing as the MSBC Manager within the Compliance Department of the HPRA, Ellen’s most recent role was Head of the Corporate Pharmaceutical Unit, which is the interface between the Health Service Executive (HSE) and pharmaceutical industry in relation to medicines pricing and reimbursement at a national level. As head of the unit Ellen was responsible for all commercial negotiations for new medicines reimbursed by the HSE, and also supported the State negotiation team to bring forward two 4-year national pricing Framework Agreements (IPHA 2021 Agreement and MFI 2021 Agreement). Ellen led the first of its kind negotiations in two successful pilot projects under the ‘Beneluxa initiative’, an international collaboration set up with an aim of providing sustainable access to innovative medicines at affordable costs for patients through joint assessment and joint decision-making on applications for reimbursement. Ellen possesses a Masters in Health Policy from Imperial College London, completing her research dissertation examining the factors influencing the outcomes of negotiated reimbursement decisions for new medicines in Ireland.
Please note that by registering for this event you agree to share your name and company details with the organisers and the event sponsor.
